Arsenic trioxide is a novel agent for combination therapy to prolong heart allograft survival in allo-primed T cells transferred mice

Transplant Immunology - Tập 25 - Trang 194-201 - 2011
Yingying Lin1, Helong Dai1, Jingjun Su2, Guoliang Yan3, Yanfeng Xi1, Henrik Ekberg4, Jibing Chen3, Zhongquan Qi1
1Organ Transplantation Institute, Xiamen University, Fujian Province, PR China
2Department of Ultrasonography, The First Affiliated Hospital of Xiamen University, Fujian Province, PR China
3Basic Medical Department of Medical College, Xiamen University, Fujian Province, PR China
4Malmö Hospital of Lund University, Malmö, Sweden

Tài liệu tham khảo

Burrows, 1994, An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein–Barr virus CTL epitope: implications for graft-versus-host disease, J Exp Med, 179, 1155, 10.1084/jem.179.4.1155 Burrows, 1997, Cross-reactive memory T cells for Epstein–Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity, Eur J Immunol, 27, 1726, 10.1002/eji.1830270720 Sprent, 2002, T cell memory, Annu Rev Immunol, 20, 551, 10.1146/annurev.immunol.20.100101.151926 Sallusto, 2004, Central memory and effector memory T cell subsets: function, generation, and maintenance, Annu Rev Immunol, 22, 745, 10.1146/annurev.immunol.22.012703.104702 Croft, 1994, Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells, J Immunol, 152, 2675, 10.4049/jimmunol.152.6.2675 Dengler, 2000, Human vascular endothelial cells stimulate memory but not naive CD8+ T cells to differentiate into CTL retaining an early activation phenotype, J Immunol, 164, 5146, 10.4049/jimmunol.164.10.5146 Chen, 2004, In vivo helper functions of alloreactive memory CD4+ T cells remain intact despite donor-specific transfusion and anti-CD40 ligand therapy, J Immunol, 172, 5456, 10.4049/jimmunol.172.9.5456 Valujskikh, 2002, Primed allospecific T cells prevent the effects of costimulatory blockade on prolonged cardiac allograft survival in mice, Am J Transplant, 2, 501, 10.1034/j.1600-6143.2002.20603.x Vu, 2006, Critical, but conditional, role of OX40 in memory T cell-mediated rejection, J Immunol, 176, 1394, 10.4049/jimmunol.176.3.1394 Minamimura, 2008, Strategies to induce marked prolongation of secondary skin allograft survival in alloantigen-primed mice, Am J Transplant, 8, 761, 10.1111/j.1600-6143.2007.02143.x Xia, 2010, Suppressing memory T cell activation induces islet allograft tolerance in alloantigen-primed mice, Transpl Int, 23, 1154, 10.1111/j.1432-2277.2010.01106.x Nicolls, 2002, CD4-dependent generation of dominant transplantation tolerance induced by simultaneous perturbation of CD154 and LFA-1 pathways, J Immunol, 169, 4831, 10.4049/jimmunol.169.9.4831 Malm, 2006, Combined costimulation blockade prevents rejection of allogeneic islets in mice, Scand J Immunol, 64, 398, 10.1111/j.1365-3083.2006.01836.x Miller, 2002, Mechanisms of action of arsenic trioxide, Cancer Res, 62, 3893 Zhang, 2001, Arsenic trioxide, a therapeutic agent for APL, Oncogene, 20, 7146, 10.1038/sj.onc.1204762 de The, 2001, APL, a model disease for cancer therapies?, Oncogene, 20, 7136, 10.1038/sj.onc.1204851 Kogan, 2010, Medicine. Poisonous contacts, Science, 328, 184, 10.1126/science.1189198 Zhang, 2010, Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML, Science, 328, 240, 10.1126/science.1183424 Bobe, 2006, Arsenic trioxide: a promising novel therapeutic agent for lymphoproliferative and autoimmune syndromes in MRL/lpr mice, Blood, 108, 3967, 10.1182/blood-2006-04-020610 Yan, 2009, Arsenic trioxide attenuated the rejection of major histocompatibility complex fully-mismatched cardiac allografts in mice, Transplant Proc, 41, 1855, 10.1016/j.transproceed.2009.02.073 Xu, 2010, Arsenic trioxide combined with co-stimulatory molecule blockade prolongs survival of cardiac allografts in alloantigen-primed mice, Transpl Immunol, 24, 57, 10.1016/j.trim.2010.07.003 Matsuura, 1991, Simplified mouse cervical heart transplantation using a cuff technique, Transplantation, 51, 896, 10.1097/00007890-199104000-00031 Winters, 1998, The International Society for Heart and Lung Transplantation grading system for heart transplant biopsy specimens: clarification and commentary, J Heart Lung Transplant, 17, 754 Billingham, 1990, A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation, J Heart Transplant, 9, 587 Yang, 2007, Allograft rejection mediated by memory T cells is resistant to regulation, Proc Natl Acad Sci U S A, 104, 19954, 10.1073/pnas.0704397104 Bingaman, 2004, Memory T cells in transplantation: generation, function, and potential role in rejection, Am J Transplant, 4, 846, 10.1111/j.1600-6143.2004.00453.x Kassiotis, 2002, Impairment of immunological memory in the absence of MHC despite survival of memory T cells, Nat Immunol, 3, 244, 10.1038/ni766 Boyman, 2009, Homeostatic proliferation and survival of naive and memory T cells, Eur J Immunol, 39, 2088, 10.1002/eji.200939444 Oppermann, 2004, Chemokine receptor CCR5: insights into structure, function, and regulation, Cell Signal, 16, 1201, 10.1016/j.cellsig.2004.04.007 Shevach, 2004, Regulatory/suppressor T cells in health and disease, Arthritis Rheum, 50, 2721, 10.1002/art.20500 Roncarolo, 2001, Type 1T regulatory cells, Immunol Rev, 182, 68, 10.1034/j.1600-065X.2001.1820105.x Chen, 2003, Conversion of peripheral CD4+CD25− naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3, J Exp Med, 198, 1875, 10.1084/jem.20030152 Fu, 2004, TGF-beta induces Foxp3+ T-regulatory cells from CD4+ CD25− precursors, Am J Transplant, 4, 1614, 10.1111/j.1600-6143.2004.00566.x Hossain, 2000, Arsenite induces apoptosis of murine T lymphocytes through membrane raft-linked signaling for activation of c-Jun amino-terminal kinase, J Immunol, 165, 4290, 10.4049/jimmunol.165.8.4290